PERIURETHRAL COLLAGEN INJECTION FOR THE TREATMENT OF URINARY-INCONTINENCE IN CHILDREN

Citation
A. Chernoff et al., PERIURETHRAL COLLAGEN INJECTION FOR THE TREATMENT OF URINARY-INCONTINENCE IN CHILDREN, The Journal of urology, 157(6), 1997, pp. 2303-2305
Citations number
10
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00225347
Volume
157
Issue
6
Year of publication
1997
Pages
2303 - 2305
Database
ISI
SICI code
0022-5347(1997)157:6<2303:PCIFTT>2.0.ZU;2-T
Abstract
Purpose: We assessed the efficacy and safety of periurethral collagen injection for urinary incontinence in children with neurogenic bladder dysfunction. Materials and Methods: We treated 11 children (mean age 10.6 years) who had incontinence and neurogenic bladder dysfunction wi th periurethral injections of glutaraldehyde cross-linked collagen. Al l patients were on anticholinergics and all but 1 were on clean interm ittent catheterization preoperatively. Four patients had previously un dergone augmentation cystoplasty. All patients were assessed before an d after injection with a subjective continence scale and multichannel urodynamics. Followup ranged from 4 to 20 months from the last injecti on. Results: Mean group Valsalva leak point pressure was 34.5 cm. wate r. Four of the 11 patients had an identifiable detrusor leak point pre ssure. Overall success rate was 55% with 4 patients dry and 2 improved . Success correlated with a minimum increase in Valsalva leak point pr essure of 20 to 25 cm. water to greater than 60 cm. water. Three patie nts had no demonstrable Valsalva leak point pressure after injection. All 5 patients in whom treatment failed had no change in Valsalva leak point pressure, including 2 with small capacity, poorly compliant bla dders preoperatively. Because they had a component of sphincteric insu fficiency, they underwent injection in the hope of increasing capacity with increased continence. In 3 patients Valsalva leak point pressure was greater than 50 cm. water. Detrusor leak point pressure developed in 3 patients postoperatively, including 1 with significantly increas ed Valsalva leak point pressure. One patient with significantly increa sed Valsalva leak point pressure had urethral hypermobility postoperat ively. Of the 3 patients who subsequently underwent augmentation cysto plasty 1 is now dry, 1 is wet and 1 died of complications unrelated to urological disease. Patients underwent 1 to 4 procedures (mean 2.5). Conclusions: Periurethral collagen injection may be effective for urin ary incontinence in patients who have adequate capacity with good comp liance and low Valsalva leak point pressure. When there is no response to repeat injections or a transient response, one should consider the possibility of bladder decompensation.